Cargando…
Aminoalkylamides of Eremomycin Exhibit an Improved Antibacterial Activity
After decades, the glycopeptide vancomycin is still the preferred antibiotic against resistant strains of Gram-positive bacteria. Although its clinical use is strictly regulated, the gradual spread of vancomycin-resistant bacteria, such as glycopeptide-resistant and glycopeptide-intermediate Staphyl...
Autores principales: | Moiseenko, Elena I., Erdei, Réka, Grammatikova, Natalia E., Mirchink, Elena P., Isakova, Elena B., Pereverzeva, Eleonora R., Batta, Gyula, Shchekotikhin, Andrey E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072890/ https://www.ncbi.nlm.nih.gov/pubmed/33921612 http://dx.doi.org/10.3390/ph14040379 |
Ejemplares similares
-
Bacterial Cell Wall Analogue Peptides Control the Oligomeric States and Activity of the Glycopeptide Antibiotic Eremomycin: Solution NMR and Antimicrobial Studies
por: Izsépi, László, et al.
Publicado: (2021) -
Eremomycin pyrrolidide: a novel semisynthetic glycopeptide with improved chemotherapeutic properties
por: Olsufyeva, Evgenia N, et al.
Publicado: (2018) -
Antibacterial Conjugates of Kanamycin A with Vancomycin and Eremomycin: Biological Activity and a New MS-Fragmentation Pattern of Cbz-Protected Amines
por: Solyev, Pavel N., et al.
Publicado: (2023) -
Evaluation of Toxic Properties of New Glycopeptide Flavancin on Rats
por: Treshchalin, Michael I., et al.
Publicado: (2022) -
Experimental Evaluation of the Hypersensitivity Reactions of a New Glycopeptide Antibiotic Flavancin in Animal Models
por: Treshchalin, Michael I., et al.
Publicado: (2023)